Manufacturers of multiple sclerosis drugs may be raising prices for the costly treatments in lockstep with each other, two Congressional Democrats said.
Rep. Elijah E. Cummings (D-Md.), ranking member of the House Committee on Oversight and Government Reform, and Rep. Peter Welch, (D-Vt.), a senior Democrat on both the Oversight Committee and the Committee on Energy and Commerce, asked seven manufacturers of the pricey to explain pricing practices for their MS drugs by Aug. 31.
The Congressmen are receiving responses from the companies and are reviewing them, a minority staffer for the House Committee on Oversight and Government Reform told me Sept. 1. Once everything is reviewed, the House members would provide an update, the staffer said.
“Some drug companies appear to be in their prices and setting new higher prices in lockstep with competitors—a strategy known as “shadow pricing,” the letters sent to Bayer Healthcare Pharmaceuticals Inc., Biogen, EMD Serono, Novartis Pharmaceuticals Corp., Sanofi Genzyme, Teva Pharmaceutical Industries Ltd. and Roche Pharmaceuticals said.
The companies were asked to provide a breakdown of their profits and expenses for their MS drugs plus additional documents, contracts and related information on the products, such as contracts with pharmacy benefit managers and distributors.
The letter to Bayer is available at http://src.bna.com/scw.
Additional letters are available at http://src.bna.com/scx.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)